You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Additional Milligram to Milligram Conversion Study Shows Equivalency of Prograf to MR Prograf SEATTLE, May 24, 2005 – Two studies presented today at the 6th American Transplant Congress (ATC)...
One Study of Early Steroid Withdrawal Reduced Cholesterol Levels and Decreased Onset of Post Transplant Diabetes SEATTLE, May 24, 2005 -- Early steroid withdrawal along with the use of tacrolimus...
ORLANDO, Fla., May 17, 2005 -- OSI Pharmaceuticals (Nasdaq: OSIP) First-Line, Monotherapy Non-Small Cell Lung Cancer Data Presented Symptom Response / Quality of Life Analysis from the...
ORLANDO, Fla., May 16, 2005 -- OSI Pharmaceuticals (Nasdaq:OSIP) provided an informational update summarizing highlights from presentations on the analysis of EGFR mutation and gene amplification...
Data Presented at Plenary Session at Annual ASCO Meeting ORLANDO, Fla., May 14, 2005 /PRNewswire-FirstCall via COMTEX/ -- Genentech, Inc. (NYSE: DNA) and OSI Pharmaceuticals (Nasdaq: OSIP) today...
Follow U.S. news
